First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia

Journal
Frontiers in Medicine
ISSN
2296-858X
Date Issued
2020
Author(s)
M. Cecilia Poli
Gigia Roizen
Vivianne Agar
Javiera Donoso
Margarita Fierro
José Montes
Type
Resource Types::text::journal::journal article
Scopus ID
2-s2.0-85096920789
WoS ID
WOS:000593894300001
DOI
URL
URL Institutional Repository
Cite this document
Valenzuela, O., Ibáñez, S., Poli, M. C., Roessler, P., Aylwin, M., Roizen, G., Iruretagoyena, M., Agar, V., Donoso, J., Fierro, M., & Montes, J. (2020). First report of tocilizumab use in a cohort of latin american patients hospitalized for severe covid-19 pneumonia. Frontiers in Medicine, 7, 596916. https://doi.org/10.3389/fmed.2020.596916
Project(s)
Subjects
tocilizumab

; 

covid-19

; 

sars-cov 2

; 

lymphocyte

; 

mechanical ventilalion

; 

aminotransferase

; 

d dimer

; 

hydroxychloroquine

; 

prednisone

; 

tocilizumab

; 

adult

; 

anticoagulation

; 

article

; 

artificial ventilation

; 

breathing disorder

; 

clinical article

; 

cohort analysis

; 

controlled study

; 

coronavirus disease 2019

; 

descriptive research

; 

drug dose reduction

; 

evaluation study

; 

female

; 

hospital patient

; 

human

; 

human cell

; 

hyperinflammation

; 

hypertension

; 

intubation

; 

leukopenia

; 

lung alveolus oxygen tension

; 

lung embolism

; 

lymphocyte count

; 

male

; 

middle aged

; 

multidisciplinary team

; 

neutropenia

; 

obesity

; 

observational study

; 

retroperitoneal hematoma

; 

retrospective study

; 

side effect

; 

south and central america

; 

treatment outcome